These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 11366860)
1. Clinical trials (studies) currently open addressing BHC, wasting and metabolic abnormalities. WORLD; 1999 Nov; (No 103):6. PubMed ID: 11366860 [TBL] [Abstract][Full Text] [Related]
2. Somatropin (mammalian cell-derived recombinant human growth hormone) for HIV-associated wasting. MacDougall DS J Int Assoc Physicians AIDS Care; 1997 Oct; 3(10):30-5. PubMed ID: 11364744 [TBL] [Abstract][Full Text] [Related]
3. Wasting and body changes: what do we know so far? Gomez E Newsline People AIDS Coalit N Y; 1998 Sep; ():34-6. PubMed ID: 11367489 [TBL] [Abstract][Full Text] [Related]
4. Wasting and lipodystrophy in patients infected with HIV: a practical approach in clinical practice. Fisher K AIDS Read; 2001 Mar; 11(3):132-3, 137-40, 147. PubMed ID: 17004351 [TBL] [Abstract][Full Text] [Related]
5. What is happening to my body? Rappoport C WORLD; 1999 Nov; (No 103):4-6. PubMed ID: 11366859 [TBL] [Abstract][Full Text] [Related]
6. Retroviruses conference reassuring on new treatments, viral targets, research. AIDS Treat News; 2002 Mar; (378):2-3. PubMed ID: 11965916 [No Abstract] [Full Text] [Related]
7. Measurement of body composition: the search for a standard. MacDougall DS J Int Assoc Physicians AIDS Care; 1997 Jan; 3(1):9-13. PubMed ID: 11363963 [TBL] [Abstract][Full Text] [Related]
8. Role of recombinant human growth hormone in HIV-associated wasting and cachexia: pathophysiology and rationale for treatment. Gelato M; McNurlan M; Freedland E Clin Ther; 2007 Nov; 29(11):2269-88. PubMed ID: 18158071 [TBL] [Abstract][Full Text] [Related]
9. Strategies for treating HIV-related lipodystrophy. García-Viejo MA; Ruíz M; Martínez E Expert Opin Investig Drugs; 2001 Aug; 10(8):1443-56. PubMed ID: 11772261 [TBL] [Abstract][Full Text] [Related]
10. NIH may fund research into marijuana therapy. National Institutes of Health. AIDS Alert; 1997 Apr; 12(4):45-6. PubMed ID: 11364148 [TBL] [Abstract][Full Text] [Related]
11. Understanding and treating protease paunch. Vazquez E Posit Aware; 1999; 10(4):59-63. PubMed ID: 11366810 [TBL] [Abstract][Full Text] [Related]
12. Editorial comment: use of recombinant human growth hormone for wasting--questions for clinical practice. Wanke C AIDS Read; 2005 Jun; 15(6):309. PubMed ID: 15962454 [No Abstract] [Full Text] [Related]
13. Lipodystrophy research coordination needed. James JS AIDS Treat News; 1998 Sep; (303):1-5. PubMed ID: 11365765 [TBL] [Abstract][Full Text] [Related]
14. The metabolic puzzle during the evolution of HIV infection. Salas-Salvadó J; García-Lorda P Clin Nutr; 2001 Oct; 20(5):379-91. PubMed ID: 11534932 [TBL] [Abstract][Full Text] [Related]
16. Use of steroids for wasting and lipodystrophy syndromes in HIV/AIDS. Frost KR AIDS Read; 2001 Mar; 11(3):130-1. PubMed ID: 17004350 [No Abstract] [Full Text] [Related]
17. Identifying and managing morphologic complications of HIV and HAART. Currier J; Carpenter C; Daar E; Kotler D; Wanke C AIDS Read; 2002 Mar; 12(3):114-9, 124-5. PubMed ID: 11966241 [TBL] [Abstract][Full Text] [Related]
18. The ball's in your court: testosterone 101. Horn T; Cooper S Notes Undergr; 1997 Nov; (No 36):1-4. PubMed ID: 11365205 [TBL] [Abstract][Full Text] [Related]
19. Open clinical trials for HIV/AIDS treatments. Stephenson K BETA; 1998 Jan; ():61-3. PubMed ID: 11364979 [TBL] [Abstract][Full Text] [Related]
20. Testing of nutritional supplement for wasting. Res Initiat Treat Action; 1999 Jan; 5(1):18. PubMed ID: 11366224 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]